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A B S T R A C T
In recent years, several computer-aided diagnosis (CAD) systems have been proposed for an early identification
of dementia. Although these approaches have mostly used the transformation of data into a different feature
space, more precise information can be gained from a Searchlight strategy. The current study presents a data
fusion classification system that employs magnetic resonance imaging (MRI) and neuropsychological tests to
distinguish between Mild-Cognitive Impairment (MCI) patients that convert to Alzheimer’s disease (AD) and
those that remain stable. Specifically, this method uses a nested cross-validation procedure to compute the
optimum contribution of each data modality in the final decision. The model employs Support-Vector Machine
(SVM) classifiers for both data modalities and is combined with Searchlight when applied to neuroimaging.
We compared the performance of our system with an alternative based on Principal Component Analysis
(PCA) for dimensionality reduction. Results show that Searchlight outperformed PCA both for uni/multimodal
classification, obtaining a maximum accuracy of 80.9% when combining data from six and twelve months
before patients converted to AD. Moreover, Searchlight allowed the identification of the most informative
regions at different stages of the longitudinal study, which can be crucial for a better understanding of the
development of AD. Additionally, results do not depend on the parcellations provided by a specific brain atlas,
which manifests the robustness and the spatial precision of the method proposed.1. Introduction
Alzheimer’s disease (AD) is the most common cause of dementia.
Nowadays, 50 million people worldwide suffer from this neurodegener-
ative disease, and its prevalence is expected to be quadrupled by 2050.
Although this disease has no cure, accurate and early diagnosis methods
are crucial to slow its progress and for the development of new drugs.
Since AD usually appears in elderly people, the symptoms in early
stages are similar to those present in aging, making the prognosis of this
disorder a challenging endeavor. The development of brain imaging
techniques has made possible to obtain vital information of patients
in a non-invasive way that complements clinical evaluations. Previous
studies have used a wide range of imaging techniques to characterize
AD. Some of them rely on functional information provided by Single
Photon Emission Tomography (SPECT, Gyasi et al., 2020; Martínez-
Murcia et al., 2012; van der Zande et al., 2020), Positron Emission
Tomography (PET, Hedderich et al., 2020; Kim, Lee et al., 2020)
or functional Magnetic Resonance Imaging (fMRI, Iordanescu et al.,
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2012; Ni et al., 2016). Other studies employed anatomical information
extracted from structural MRI (sMRI, Hedderich et al., 2020; Kenkhuis
et al., 2019), such as measures of cortical thickness (Lerch et al.,
2004; Ossenkoppele et al., 2019), voxel-based morphometry (Baron
et al., 2001; Hirata et al., 2005) or volume measures of specific brain
regions (Shen et al., 2011; Stein et al., 2012).
With the advance of machine learning, computer aided diagnosis
(CAD) systems have been successfully used as a tool in the study of
neurodegeneration and diagnosis of AD. Recent approaches rely on
multivariate analysis, a technique that employs the patterns contained
in groups of voxels to make a classification decision (Bucholc et al.,
2019; Martínez-Murcia et al., 2012; Mourão-Miranda et al., 2005). The
use of these methods in the study of AD has two main aims: first,
obtaining the maximum classification performance at the earliest stage
of the disease; second, localizing the brain regions that are first affected
to use them as biomarkers of neurodegeneration.vailable online 13 July 2021
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Expert Systems With Applications 185 (2021) 115549J.E. Arco et al.One of the challenging problems in the development of a classifica-
tion system for neuroimaging is related to the so-called small sample
size problem (Duin, 2000). This kind of images usually has a high
dimensionality (e.g. voxels), but datasets are formed by a relatively
low number of images, which can lead to overfitting and poor general-
ization performance (Subramanian & Simon, 2013; Varoquaux, 2018).
The simplest approach for reducing the dimensionality is limiting the
analyses to a specific brain region instead of using the voxels contained
in the whole brain. This is known as region of interest (ROI) analysis,
and it is particularly useful when there is a priori knowledge about
the role of a region in the development of a neurological disease.
The hippocampus is especially vulnerable to damage at early stages
of AD (Peng & Bonaguidi, 2018), so hippocampal volume combined
with different features from multi-modal imaging has been previously
used for discriminating AD patients (Amoroso et al., 2018; Gupta
et al., 2019). Other studies have used groups of regions provided by
a specific atlas instead of a region, allowing the evaluation of their
relevance (Schrouff et al., 2018). However, parcellations proposed by
atlases do not match the actual organization of the brain of all patients,
which can reduce their usefulness.
Previous studies have focused on the early detection of AD while
providing information about the brain regions that are first affected
by this disease. Górriz et al. (2008) presented a method that divided
SPECT images into different regions (spatial components) and then
combined the classification performed in each one of them. The accu-
racy associated with each component was then summarized in a map of
regions of interest. Cabral et al. (2015) evaluated the ability of machine
learning for an early prediction of AD for different instants before
the conversion occurred. Specifically, they used mutual information as
feature selection previous to the classification stage. The importance of
each region in the development AD was established according to their
average mutual information value. Ezzati et al. (2019) optimized dif-
ferent machine learning methods to improve predictive models of AD.
They compared the performance of six classifiers in the discrimination
of the development of AD based on 47 cortical and subcortical regions.
This means that the selection of the informative regions was done a
priori.
These studies show that it is crucial for an early diagnosis of AD
to identify the brain regions that guide the decision of the classi-
fier. In Cognitive Neuroscience, the use of Searchlight is widespread
for localizing the brain regions involved in a certain psychological
process (Kriegeskorte et al., 2006). Searchlight has become the most
common approach for analysis of fMRI data. A large number of studies
have brought new insights into the localization of human brain func-
tion (Arco et al., 2018; Coutanche et al., 2011; González-García et al.,
2017; Soon et al., 2008). Although this approach is not widely used
in CAD systems, its use in this context could be highly beneficial for
two main reason. First, Searchlight addresses the high dimensionality
problem without using any geometric transformation, which preserves
the spatial information of the original space. And most important,
Searchlight is completely data-driven: it does not assume that the
neurological damage is located in a specific brain region but empirically
evaluates the classifier’s performance in all the positions of the brain.
Regions where the classifier obtains a better performance correspond
to regions that contain high differences between the two groups.
Another important aspect is given by the benefits of combining
different classifiers within a CAD system, which is termed ensemble
classification. Some studies employed data from different image modal-
ities in addition to other biological measures such as cerebrospinal
fluid assays or APOE genotype (Hinrichs et al., 2011). Ortiz et al.
(2014) developed an algorithm to fuse PET and MRI data that out-
performed other alternatives where single-modality images were used,
whereas Lazli et al. (2018) relied on the combination of anatomical
and functional images in addition to genetic algorithms. The use of
neuropsychological scores is widespread in the diagnosis of dementia2
since they are relatively inexpensive and innocuos for patients. Segoviaet al. (2014) combined neuropsychological tests with functional images
in the diagnosis of dementia, obtaining a boost in accuracy when
information from tests was used. Similarly, Korolev et al. (2016) used
clinical and plasma biomarkers, in addition to volume and cortical
thickness of three brain regions (left hyppocampus, middle temporal
gyrus and inferior parietal cortex) to predict the progression of AD.
The dramatic increase in the prevalence of the AD evidences the
importance of developing intelligent systems that help clinicians in the
study of this disease. In this work, we propose a data fusion classifier
based on Searchlight for an early detection of AD while providing a
map of the brain regions that are first damaged. We combine different
MR scanning sessions of the longitudinal study within an ensemble
framework, employing an individual classifier for each source of in-
formation (MRI scans and neuropsychological tests). Decision of each
classifier is fused into a global one according to its performance: the
higher the accuracy, the higher the contribution. Besides, we compare
the results obtained by our system with a baseline approach where PCA
is employed instead of Searchlight. The system is evaluated in a real
scenario where identifying AD features in a preclinical stage. The main
contributions of our work can be summarized as follows:
• A novel and accurate tool for an early detection of AD from MRI
scans and neuropsychological tests.
• The use of Searchlight provides a crucial spatial information for
detecting the brain areas affected by this disease.
• The data fusion scheme allows the combination of different
modalities to predict the development of the pathology.
• Decisions of individual classifiers are combined according to their
relevance in the classification framework.
• The data-driven nature of our method allows its application with-




The data used in the preparation of this paper were obtained
from the Alzheimer’s Disease Neuroimaging Initiative (ADNI) database
(adni.loni.usc.edu). The ADNI was launched in 2003 by the National
Institute on Aging (NIA), the National Institute of Biomedical Imaging
and Bioengineering (NIBIB), the Food and Drug Administration (FDA),
private pharmaceutical companies and non-profit organizations, as a
$60 million, 5-year public–private partnership. The primary goal of
ADNI has been to test whether serial MRI, PET, other biological mark-
ers, and clinical and neuropsychological assessment can be combined
to measure the progression of MCI and AD. Determination of sensitive
and specific markers of very early AD progression is intended to aid
researchers and clinicians to develop new treatments and monitor their
effectiveness, as well as lessen the time and cost of clinical trials. The
Principal Investigator of this initiative is Michael W. Weiner, MD, VA
Medical Center and University of California, San Francisco. ADNI is
the result of efforts of many co-investigators from a broad range of
academic institutions and private corporations, and subjects have been
recruited from over 50 sites across the U.S. and Canada. The initial goal
of ADNI was to recruit 800 subjects but ADNI has been followed by
ADNI-GO and ADNI-2. To date these three protocols have recruited over
1500 adults, ages 55–90, to participate in the research, consisting of
cognitively normal older individuals, people with early or late MCI, and
people with early AD. The follow up duration of each group is specified
in the protocols for ADNI-1, ADNI-2, and ADNI-GO. Subjects originally
recruited for ADNI-1 and ADNI-GO had the option to be followed in
ADNI-2. For up-to-date information, see www.adni-info.org.
The experiments conducted in this paper used only ADNI subjects
whose data (MRI, MMSE and ADAS-Cog) was available for all sessions

























Diagnose Number Sex M/F Age MMSE ADAS-Cog
MCI - C 73 38/35 76.31 ± 6.01 25.5 ± 2.21 22.81 ± 5.51
MCI - NC 61 35/26 75.19 ± 6.36 27.63 ± 1.7 16.27 ± 5.32
of the longitudinal study. We aimed at employing data from two scan-
ning sessions in order to develop a classifier to predict the conversion
from MCI to AD in the next session. For this reason, we only took MCI-
C subjects that converted to AD in the third session as the earliest.
This led to a total of 134 MCI subjects, including 73 that converted
to AD in any of the sessions (MCI-C) and 61 that remained stable along
the study (MCI-NC). Fig. 1 shows the number of MCI patients who
converted to AD in each session of the longitudinal study, whereas
demographics of all participants are included in Table 1. For MCI-C
patients, we analyzed data belonging to two sessions previous to their
conversion. Regarding MCI-NC patients, they remained stable during
the six sessions, which means that results in terms of MRI and tests did
not change much along time. However, it was necessary to select data
from two sessions in order to compare them with MCI-C patients. To do
so, we computed the average conversion session of the MCI-C subjects
in order to minimize the bias of the subsequent analysis. Given that this
session was the fourth one, data from the second and the third session
were evaluated. Fig. 2 provides a scheme of this procedure.
2.2. Image preprocessing
The first step employed in the preprocessing of the T1 images was
registration. This process applied a spatial transformation based on the
exponential Lie algebra proposed in Ashburner (2007), ensuring that
each voxel in the image corresponded to the same anatomical position
across subjects. The resulting MRI images were then resized to 121 ×
45 × 121 voxels with voxel-sizes of 1.5 mm × 1.5 mm × 1.5 mm. After
hat, images were segmented into gray matter (GM) and white matter
WM) tissues using the algorithms contained in SPM (Ashburner &
riston, 2005). The SPM segmentation tool provided the intensity value
istribution of the T1-weighted MRI by employing tissue probability
aps of GM, WM and cerebro-spinal fluid (CSF). These maps computed
he probability that each voxel belonged to GM, WM and CSF. After
hat, a non-linear deformation field was estimated to find the one
hat best fitted the tissue probability maps of each individual subject.
he segmentation stage produced images denoting the membership
robability to each of the three tissues. No additional step such as
moothing or dimension reduction was applied.3
3. Methods
In this study, we proposed a method based on Searchlight for the
classification of MCI patients. We also employed PCA as a baseline
for reducing the dimensionality of the input data before the classifica-
tion. Finally, we studied the effect of combining different sources of
information within an ensemble framework. To do so, one classifier
received MRI scans as input data whereas neuropsychological tests
were entered into a second classifier. A crucial aspect we focused on
was how predictions of each individual classifier were combined. Thus,
the different approaches contained in this section are:
• PCA + SVM
• Searchlight + SVM
• Ensemble + PCA + SVM
• Ensemble + Searchlight + SVM
Fig. 3 provides an overview of the different stages of the classifica-
ion framework evaluated in this work.
.1. Feature extraction
.1.1. Principal component analysis
PCA is a mathematical technique that projects data to a lower
imension to facilitate the extraction of information (Jolliffe, 2002).
pecifically, each image is decomposed as a linear combination of
ifferent components, so that only a few of them are then used for the
ubsequent classification. The dimensionality reduction of the brain im-
ges is performed as follows López et al. (2011). Let 𝐘 = [𝐘1,𝐘2,… ,𝐘𝑛]
be a set of 𝑛 images (one for each subject of the database), after being
normalized and mean subtracted, where 𝐘𝑖 = (𝑦𝑖1, 𝑦𝑖2,… , 𝑦𝑖𝑁 )𝑡 and 𝑁
reflects the dimensionality of the images. The covariance matrix of the




where the eigenvector and eigenvalue matrices Γ, Λ are computed as:
𝐂Γ = ΓΛ (2)
Since the dimensionality of the image is larger than the number of im-
ages, then diagonalizing 𝐘𝑡𝐘 instead of 𝐘𝐘𝑡 reduces the computational
burden (Turk & Pentland, 1991):
(𝐘𝑡𝐘)Φ = ΦΛ∗ (3)
Γ∗ = 𝐘Φ (4)
where Λ∗ = 𝑑𝑖𝑎𝑔(𝜆1, 𝜆2,… , 𝜆𝑁 ) and Γ∗ = [Γ1,Γ2,… ,Γ𝑁 ] are the
first 𝑁 eigenvalues and eigenvectors, respectively. The images are then





Fig. 2. Diagram of the longitudinal study conducted by ADNI. We only focused on MCI patients. For MCI converters (MCI-C), images and tests belonging to one, two or both
revious sessions to the conversion were employed for classification. As an example, if the patient converted to AD in the last session (‘3 year’), data from ‘2 year’ and ‘Month
8’ were selected, corresponding to six and twelve months before the conversion, respectively. For MCI non-converters (MCI-NC), images and tests belonging to one, two or both
revious sessions to the average conversion session of MCI-C were employed. Since ‘Month 18’ session was the average one, data from ‘Month 6’ and ‘1 year’ were selected for
CI-NC.Fig. 3. Schematic representation of the classification framework used. The pipeline differs in the feature extraction block (PCA or Searchlight) and depending on information from
neuropsychological tests is employed or not. If so, individual classifiers (MRI and tests) are combined within an ensemble method.i
projected over the eigenvectors, which are also known as principal
components. We estimated the importance of these components in
terms of their contribution to the total variance of the dataset. Only
the components that explained 75% of the total variance (Segovia et al.,
2014) are entered into the SVM classifier (see Section 3.2).
3.1.2. Searchlight
Searchlight addresses the small sample size problem by restricting
the analysis to reduced groups of voxels. Specifically, this approach
defines a small sphere that is centered in a specific position of the
brain. Only the voxels that are contained in the sphere are entered into
the classifier. The resulting accuracy is then assigned to the central
voxel of the sphere. The main idea of this technique and the reason
why it provides an excellent spatial information is that the sphere
sweeps all the positions of the brain. This means that once the sphere
has been centered in all voxels, a map of accuracies is obtained (see
Fig. 4 for a visual explanation). The value of each position denotes the
accuracy of the classifier when the voxel was the center of the sphere.
Positions with high accuracies correspond to brain regions evidencing
high differences between the two classes.
We employed in each sphere an SVM classifier with a lineal kernel
due to its simplicity and the high performance reported by previous
studies (Arco et al., 2019; Misaki et al., 2010). Regarding the size of
the sphere, we used a 17-mm radius one to strike a balance between
performance and execution time (Arco et al., 2015). Despite the result-
ing accuracy map provides information at the voxel level, it is necessary4
to evaluate results at the region level in order to compare them withthe ones obtained by PCA. To do so, we divided the accuracy map into
116 regions as proposed by AAL atlas (Tzourio-Mazoyer et al., 2002).
Then, we computed the average accuracy of the voxels contained in






with 𝑣 representing the index of a voxel in the accuracy map, 𝑎𝑐𝑐𝑣
ts accuracy and 𝑁𝑅𝑂𝐼 the number of voxels contained in region ROI.
The accuracy (𝐴𝑐𝑐𝑅𝑂𝐼 ) is a measure of the information contained in a
specific brain region. A large value means that the classification model
allows a good separation of the patterns contained in the ROI associated
with each group of patients. The 116 regions proposed by this atlas are
illustrated in Fig. 5.
Given that Searchlight is a data-driven approach, it can be used
for studying the role of a specific brain region in the development of
AD without making any prior assumption. However, it is also highly
useful for classifying between different patients according to their brain
damage. Specifically, we employed the Searchlight sphere that led to
the maximum accuracy for a dual function: (i) to locate the regions
most affected in the first developmental stages of the disease, and (ii)
to develop a CAD system as an early-warning classifier.
3.2. Support vector machines
Components or voxels within the sphere (depending on whether
PCA or Searchlight was applied) were then used as input of an SVM
classifier. This approach employs the hyperplane with the maximum
Expert Systems With Applications 185 (2021) 115549J.E. Arco et al.Fig. 4. Schematic representation of a 2D Searchlight analysis. The classifier receives as input the voxels contained in a sphere, assigning the resulting accuracy to the central
voxel. The sphere is centered in all the positions of the brain, leading to an accuracy map.Fig. 5. View of the 116 labeled regions defined in the AAL atlas.
separation between classes to distinguish between them. This separa-
tion is known as margin, and the nearest data points are usually termed
support vectors. From a mathematical perspective, it is possible to
specify a linear SVM classification rule 𝑓 by a pair of (𝐱, 𝐱), as follows:
𝑓 (𝐱𝑖) = ⟨𝐰, 𝐱𝑖⟩ + 𝑏 (6)
where 𝐰 is the weight vector, 𝐱𝑖 is the feature vector and 𝑏 is the error
term. Thus, a point 𝑥 is classified as positive if 𝑓 (𝑥) > 0 or negative if
𝑓 (𝑥) < 0. The maximum distance between the two classes is obtained







𝑦𝑖(⟨𝐰, 𝐱𝑖⟩ + 𝑏) ≥ 1 − 𝜉𝑖 ∀𝑖𝜉𝑖 ≥ 0 ∀𝑖
(7)
where 𝐶 is usually known as penalty for misclassification, or cost






𝑖=1after applying the Lagrangian multipliers. Substituting the value of 𝐰






𝛼𝑖𝐾(𝐱, 𝐱𝑖) + 𝑏 (9)
where 𝛼𝑖 and 𝑏 represent the coefficients to be learned from the ex-
amples and 𝐾(𝐱, 𝐱𝑖) is the kernel function characterizing the similarity
between samples 𝐱 and 𝐱𝑖.
3.3. Ensemble classification
The methods described in previous sections were applied to MRI
scans. However, the dataset contains additional information (results
from neuropsychological tests) that can be helpful for the early detec-
tion of AD. It is possible to combine data from different modalities
by employing an ensemble classification framework. From a theo-
retical standpoint, ensemble classification refers to the combination
of classifiers to provide a unified and more accurate response than
individual classifiers to unseen data (Castillo-Barnes et al., 2018; Liu
et al., 2012; Rokach, 2010; Segovia et al., 2014). Ensemble schemes
usually improve the classification performance, especially when each
independent classifier receives complementary information. A crucial
step is to select how different information is combined. One option
is known as fusion, and consists on combining the decisions of each
individual classifier to predict the output class. An alternative, known
as selection, is based on choosing only the output of a single member
of the ensemble according to a specific criterion. Previous research
has demonstrated a superior performance of the fusion framework
when applied to neuroimaging (Castillo-Barnes et al., 2018; Segovia
et al., 2016). For this reason, we employed a modified version of this
approach.
Let assume that the output of each individual classifier 𝑖 is a vector
of 𝑘 elements 𝑝𝑖,1,… , 𝑝𝑖,𝑘 where 𝑝𝑖,𝑗 represents the support that instance
𝐱 belongs to class 𝑗 according to the classifier 𝑖. It is also supposed that
the support of each classifier that exemplar belongs to all the possible




𝑝𝑖,𝑗 = 1 (10)
The fusion approach employed relies on a weighting method, which
means that classifiers do not equally contribute to the global decision.
Weights for each classifier are not fixed but dynamically computed.
A standard way for setting their contribution (𝑤 ) is to employ the𝑖













After computing the weights for each classifier, classes with the highest
score are selected as follows:






where 𝑦𝑘(𝐱) represents the classification of the 𝑘th classifier and 𝑔(𝑦, 𝑐)
is the function defined as follows:
𝑔(𝑦, 𝑐) =
{
1 𝑦 = 𝑐
0 𝑦 ≠ 𝑐
(13)
It is worth noting that weights of each individual classifier are
normalized and their sum is equal to 1. Thus, we can interpret the
sum shown in Eq. (12) as the probability that 𝐱𝑖 is classified into 𝑐𝑗 .
In order to penalize the contribution of below-chance classifiers to the
global decision, we set to 0 the weights of those classifiers that obtain
an accuracy lower than 50% in the validation set, as reflected in:
𝑤(𝑤𝑖) =
{
𝑓 (𝛼𝑖) 𝛼𝑖 ≥ 0.5
0 𝛼𝑖 < 0.5
(14)
where 𝑓 (𝛼𝑖) denotes the contribution of each classifier. The simplest
approach is to use the accuracy obtained in the validation subset (inner
fold of Fig. 6). Thus, 𝑓 (𝛼𝑖) = 𝑎𝑐𝑐𝑖𝑛𝑛 in this case. Another possibility is
to assign a larger contribution to classifiers with higher accuracies. We
have employed a windowing approach that increased the contribution
of high-scoring classifiers, penalizing the ones with lower performance.
To do so, we used the different functions proposed in Castillo-Barnes
et al. (2018): linear, quadratic and exponential, defined as follows:
𝐿𝑖𝑛𝑒𝑎𝑟 𝑓 (𝛼𝑖) = 𝑎𝛼𝑖 + 𝑏
𝑄𝑢𝑎𝑑𝑟𝑎𝑡𝑖𝑐 𝑓 (𝛼𝑖) = 𝑎𝛼2𝑖 + 𝑏𝛼𝑖 + 𝑐
𝐸𝑥𝑝𝑜𝑛𝑒𝑛𝑡𝑖𝑎𝑙 𝑓 (𝛼𝑖) = 𝑎𝑒𝑏𝛼𝑖 + 𝑐
(15)
There are two conditions that these expressions should match:
𝑓 (𝛼𝑖) = 1 when 𝛼𝑖 = 1 and 𝑓 (𝛼𝑖) = 0 when 𝛼𝑖 = 0.5. Assuming that
𝑎 = 1 in the exponential cases, Eq. (15) can be rewritten as follows:
𝐿𝑖𝑛𝑒𝑎𝑟 𝑓 (𝛼𝑖) = 2𝛼𝑖 − 1
𝑄𝑢𝑎𝑑𝑟𝑎𝑡𝑖𝑐 𝑓 (𝛼𝑖) = 𝛼2𝑖 + 0.5𝛼𝑖 − 0.5
𝐸𝑥𝑝𝑜𝑛𝑒𝑛𝑡𝑖𝑎𝑙 𝑓 (𝛼𝑖) = 𝑒0.9624𝛼𝑖 − 1.618
(16)
The ensemble classification framework proposed in this work is
formed by two or three classifiers depending on the number of sessions
of the longitudinal study included. One possibility is to use data from
the previous session to the conversion one. In this case, the ensemble
would consist of two members: one for classifying the MRI scans and
another one for the neuropsychological tests. An alternative is to em-
ploy data from the two previous sessions. In this context, the ensemble
would be formed by three classifiers: the first would be focused on the
MRI scans one year before the conversion to AD, the second one would
rely on the MRI scans six months before the conversion and the third
would receive as input the tests for both sessions. Table 2 includes a
brief summarization of the different schemes employed in addition to
their associated labels employed in Section 4.
3.4. Performance evaluation
To validate the classification results both for individual and ensem-
ble frameworks, we employed a K-fold cross-validation procedure (Ko-
havi, 1995). This approach works in rounds: in each one of them, the
dataset is randomly divided into groups of k observations. The classifier
is then trained with all groups but one, whereas the remaining one is6
used for testing. We did not employ a leave-one-out cross-validationTable 2
Description of the different experiments performed in this work. We applied
PCA/Searchlight on MRI data before entering the SVM classification, whereas tests
were directly used as input of the classifier. Each data modality was evaluated from
the previous session to the conversion one (t-1), from the session before to the previous
to the conversion one (t-2) or both sessions (t-1 + t-2).
Experiment Description
PCA-MRI(t-1) PCA applied to MRI data from the previous session to the
conversion one
PCA-MRI(t-2) PCA applied to MRI data from the session before to the
previous to the conversion one
SL-MRI(t-1) Searchlight applied to MRI data from the previous session to
the conversion one
SL-MRI(t-2) Searchlight applied to MRI data from the session before to
the previous to the conversion one
Tests(t-1) Tests from the previous session to the conversion one
Tests(t-2) Tests from the session before to the previous to the
conversion one
strategy to speed up the process since both Searchlight and ensemble
classification are computationally demanding. The scheme used in en-
semble classification relies on a nested cross-validation for optimizing
the cost parameter of the SVM classifier and the contribution of each
individual classifier in the final decision (Castillo-Barnes et al., 2018).
A detailed explanation of the process is provided in next paragraph:
• Input data (MR scans, neuropsychological tests or both) are di-
vided into two groups corresponding to the train and test sets. As
we used a K -fold cross-validation schema for the outer loop, the
training set consists of 𝐾−1 subsets whereas the remaining subset
is used as the test set.
• The inner loop also employed a K -fold cross-validation. This
means that the training set is again split into 𝐾 subsets, K-1
for training and 1 for testing. The new training subset is used
to generate the classification model of each individual classifier
(based on neuroimaging or neuropsychological tests), whereas
the performance of these models is evaluated by the new testing
partition. The accuracy of each model is then used to compute
the weights of each individual classifier: those with a better
performance will have a larger contribution to the final decision
of the ensembled classifier.
• Once weights are computed, a model for each data modality is
fitted by employing the original training set provided by the outer
loop, whereas the performance of those models is evaluated with
data belonging to the test set.
• Finally, the global decision of the ensemble schema is given by a
combination of the individual predictions of each classifier.
It is worth mentioning that ensemble classification adapts to the
terative nature of Searchlight: the process described above is repeated
or each individual sphere. Fig. 6 depicts a general diagram of the
rocedure.
The performance of the classification scheme was evaluated in terms
f accuracy, sensitivity (true positive rate), specificity (true negative
ate) and precision, as follows:
𝐴𝑐𝑐 =
𝑇𝑃 + 𝑇𝑁











where 𝑇𝑃 is the number of MCI-C patients correctly classified (true
positives), 𝑇𝑁 is the number of MCI-NC patients correctly classified
(true negatives), 𝐹𝑃 is the number of MCI-NC subjects classified as MCI-
C (false positives) and 𝐹𝑁 is the number of MCI-C patients classified
as MCI-NC (false negatives). We also employed the area under the
curve ROC (AUC) as an additional measure of the classification per-
formance (Hajian-Tilaki, 2013; Mandrekar, 2010). Since classes were
Expert Systems With Applications 185 (2021) 115549J.E. Arco et al.Fig. 6. Ensemble classification flowchart. In the most complex scenario, information is individually entered into three different classifiers: MRI from the previous session to the
conversion one, MRI from the session before to the previous to the conversion one, and neuropsychological tests from those sessions. The contribution of each classifier to the
final decision is given by the accuracy obtained in the inner cross-validation loop from training data.slightly unbalanced (the number of MCI-C patients was higher than
MCI-NC ones), we computed the balanced accuracy to evaluate the
performance of the classification models. For a binary classification, the
balanced accuracy is computed as the average of the accuracy obtained
in the images belonging to each experimental condition individually,
which increases the robustness of the performance evaluated when
there classes are not balanced (Brodersen et al., 2010, 2011).
Once performance of each classification framework is computed, it
is crucial to assess its statistical significance. To do so, non-parametric
tests based on permutations were performed. Following the process
detailed in Golland and Fischl (2003), labels were first shuffled and
classification was performed. This procedure was repeated a large
number of times, yielding an empirical distribution of the accuracies.
The probability of obtaining a certain accuracy was then assessed by
comparing the accuracy obtained after training the classifier with the
actual labels and the empirical distribution. The subsequent p-value can
be computed as follows:
𝑝 = 1 + 𝑛
𝑁
(18)
where 𝑛 is the number of accuracies from the empirical distribution
that surpass the actual accuracy and 𝑁 is the number of samples used
to build the empirical distribution. To evaluate the significance of a
certain accuracy, it is necessary to compare the p-value associated
with that accuracy with a significance threshold previously established
(e.g. 𝑝 < 0.01). We can conclude that an accuracy is significant if the
associated p-value is lower than the significance threshold.
Additionally, we evaluated the statistical significance of the false
positive rate of each individual classification framework as proposed
in Eklund et al. (2016). To do so, we employed data (neuroimaging and
neuropsychological tests) from 122 healthy controls, divided them into
two random groups and performed classification, repeating this process7
1000 times. Once the empirical distribution of the accuracies was
obtained, a one-sample t -test was applied (p < 0.05). Since there was
no difference between the two groups, the proportion of the analyses
that yielded significant results was a measure of the false-positive rate
of the classification method.
4. Results
In this work we proposed a classification framework for an early
diagnosis of AD that simultaneously identified the brain regions that
were affected by this disease. We defined two main experiments:
• Experiment 1: Classification between MCI-C and MCI-NC by
employing an individual classifier that relied only on neu-
roimaging data. The classification system was based on Search-
light, whereas PCA was used as baseline. We evaluated the per-
formance of both methods when analyzed data from gray/white
matter and both (whole brain). Additionally, we divided the
Searchlight accuracy maps into the different brain parcellations
provided by the AAL atlas to identify the most relevant regions.
We did not apply this operation for the PCA results due to the
nature of this technique: the dimensionality reduction that it
performs leads to a lost of spatial information.
• Experiment 2: Evaluation in the same classification context
of an ensemble framework in which individual classifiers were
combined to take a global decision. Data from neuroimaging and
neuropsychological tests were entered into individual classifiers,
as well as data from different sessions of the longitudinal study.
Moreover, we evaluated different functions for combining the
decisions of individual classifiers and assessed their effect in the
performance of the ensemble.
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Summary of the results obtained by the different individual classification methods. The values of sensitivity, specificity, precision and AUC for systems based on Searchlight
correspond to the voxel with largest accuracy.
Experiment Description Accuracy (%) Sensitivity (%) Specificity (%) Precision (%) AUC
1 PCA-MRI(t-1)-GM 63.83 66 61.76 60.82 0.708
2 PCA-MRI(t-1)-WM 56.83 68.53 46.33 55 0.638
3 PCA-MRI(t-1)-All brain 63.54 69.2 62.1 63.14 0.745
4 PCA-MRI(t-2)-GM 62.28 64.13 60.52 61.1 0.685
5 PCA-MRI(t-2)-WM 59.84 56.93 62.29 59.28 0.659
6 PCA-MRI(t-2)-All brain 64.34 63.8 64.48 63.39 0.696
7 SL-MRI(t-1)-GM 79.81 86.89 72.73 70.48 0.815
8 SL-MRI(t-1)-WM 74.75 74.76 74.12 69.89 0.781
9 SL-MRI(t-1)-All brain 76.53 80.33 72.73 69.52 0.77
10 SL-MRI(t-2)-GM 75.89 75.41 76.36 69.19 0.785
11 SL-MRI(t-2)-WM 78.97 82.36 74.87 68.21 0.795
12 SL-MRI(t-1)-All brain 76.35 83.61 69.09 70.45 0.781Table 4
Results obtained for the different classification approaches when applied to healthy
controls (0.05 significance level).
Experiment Description p-value
1 PCA-MRI(t-1) 1.7 × 10−4
2 PCA-MRI(t-2)-GM 8.94 × 10−7
3 PCA-MRI(t-1) + Tests(t-1) 0
4 PCA-MRI(t-2) + Tests(t-2) 0





8 SL-MRI(t-1) + Tests(t-1) 0.2662
9 SL-MRI(t-2) + Tests(t-2) 0.96
10 SL-MRI(t-1) + Tests(t-1) + SL-MRI(t-2) +
Tests(t-2)
0.458
In both experiments, we only took into account results derived from
above-chance accuracies that were statistically significant. We provided
additional performance measures widely used in medical diagnosis for
assessing the goodness of the classifier, such as sensitivity, specificity,
precision or area under the curve ROC (AUC).
4.1. Individual classifications
We first focus on comparing the performance obtained by PCA and
Searchlight when MR images were the only source of information. Ta-
ble 3 summarizes the results in terms of different performance measures
when analysis focused on gray/white matter or both tissues (whole
brain). The first approach, PCA, yielded an accuracy of 63.83% six
months before the conversion session. With reference to Searchlight,
our results show a considerably boost in performance. Specifically,
this approach obtained an accuracy of 79.81%. This highlights that
the way PCA addresses the small-sample size problem is suboptimal
compared to the one proposed by Searchlight. When classification
was performed twelve months before the conversion, PCA obtained
a maximum accuracy of 64.34%. This value is slightly higher than
the one obtained in the scanning session previous to the conversion.
Regarding Searchlight, the maximum accuracy considerably increased
compared to PCA (78.26%, see Table 3 for quantitative results). We
observed that performance was very similar regardless of the session
evaluated. This likely reflects that although the brain impairment of
patients evolved across the longitudinal study, their brain already
presented neurological damage in the initial sessions since they were
diagnosed with MCI. We further discuss the implications of this finding
in Section 5.
On the other hand, maximum accuracies were obtained for analyses
focused on different brain tissues: gray matter for PCA and Searchlight
six months before the conversion (63.83% and 79.81%, respectively),
and whole brain/white matter for PCA/Searchlight twelve months
before the conversion (64.34% and 78.26%, respectively). These re-8
sults suggest that changes in white matter can also be used as apredictor of AD. A complete interpretation of the large classification
performance from regions contained in white matter is provided in
Section 5, whereas Fig. 7 shows the ROC curves obtained by the
different classification systems. Moreover, Searchlight yielded a smaller
false positive rate compared to PCA in all the scenarios evaluated.
Specifically, results obtained by PCA frameworks when applied to data
from healthy controls were significant at .05 level since their p-value
was lower than the significance level (see Table 4). Instead, none of the
methods based on Searchlight were able to reject the null hypothesis.
This speaks in favor of Searchlight alternatives since there was no
difference between the sample evaluated. These findings evidence a
lower false positive rate for Searchlight approaches and highlight their
suitability for clinical contexts, when minimizing the number of false
positives is crucial.
4.2. Ensemble classification
The combination of neuroimaging and neuropsychological tests im-
proved the performance of both classification frameworks. However,
the effect in results of ensemble classification was considerably dif-
ferent for PCA and Searchlight (see Table 5). In the previous session
to the conversion, PCA yielded an accuracy of 73.41%, which differs
substantially from the results obtained when applied only to neu-
roimaging: 63.83%. In contrast, results from Searchlight showed a
slight decrease in performance, from 79.81% to 78.48%. This likely
reflects that the information provided by the two neuropsychological
tests did not improve the classification performance when Searchlight
was the only technique applied, highlighting the suitability of this ap-
proach in the analysis of neuroimaging data. A complete interpretation
of the implications of this finding is provided in Section 5.
When applying both approaches to data twelve months prior to
the conversion session, PCA also obtained a higher improvement in
performance than Searchlight. Specifically, PCA yielded an accuracy
of 72.03%, whereas the accuracy was 77.34% after employing Search-
light. In this case, both results outperformed the ones obtained by
individual classification. It is worth mentioning that Searchlight ob-
tained a maximum accuracy of 78.26% relying only on neuroimaging
data, which is superior to the 77.34% value obtained in the ensemble
framework. However, all the analyses carried out combining neu-
roimaging and tests have been focused on gray matter because it is
widespread in literature (Basheera & Sai Ram, 2019; Kim, Park et al.,
2020; Long et al., 2017; Wang et al., 2019). Since the effect of ensemble
classification in performance of both frameworks is similar regardless
of the session evaluated, the same conclusions can also be applied to
the analysis twelve months before conversion.
We also built an ensemble scheme formed by three different classi-
fiers according to the input data. The first one employed neuroimaging
from the previous session to the conversion. The second also relied
on neuroimaging, but twelve months prior to the conversion. Finally,
the third classifier used neuropsychological tests for the two sessions
previous to the conversion. Results summarized in Table 5 show that
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Summary of the results obtained by the different ensemble classification methods. The values of sensitivity, specificity and precision for systems based on Searchlight correspond
to the sphere with the largest accuracy.
Experiment Description Acc (%) Sens (%) Spec (%) Prec (%)
1 PCA-MRI(t-1) + Tests(t-1) 73.11 69.58 77.31 77.36
2 PCA-MRI(t-2) + Tests(t-2) 72.03 70.33 73.57 75.31
3 PCA-MRI(t-1) + Tests(t-1) + PCA-MRI(t-2) + Tests(t-2) 70.09 75.01 65.35 70.13
4 SL-MRI(t-1) + Tests(t-1) 78.48 81.29 81.94 82.38
5 SL-MRI(t-2) + Tests(t-2) 77.34 79.17 80.34 79. 25
6 SL-MRI(t-1) + Tests(t-1) + SL-MRI(t-2) + Tests(t-2) 80.9 85.33 82.93 84.43Table 6
Accuracies obtained by the different ensemble methods for all the functions used for combining the weights of individual classifiers.
Experiment Description Weights Linear Quadratic Exponential
1 PCA-MRI(t-1) + Tests(t-1) 73.41 73.41 73.41 73.41
2 PCA-MRI(t-2) + Tests(t-2) 72.03 72.03 72.03 72.03
3 PCA-MRI(t-1) + Tests(t-1) + PCA-MRI(t-2) + Tests(t-2) 69.59 67.77 67.77 67.77
4 SL-MRI(t-1) + Tests(t-1) 78.48 78.48 78.48 78.48
5 SL-MRI(t-2) + Tests(t-2) 77.34 77.34 77.34 77.34
6 SL-MRI(t-1) + Tests(t-1) + SL-MRI(t-2) + Tests(t-2) 80.9 75.1 75.1 75.1combining the outputs of these three classifiers did not lead to a
superior performance when PCA was applied. However, Searchlight
obtained the largest performance of all the experiments evaluated when
combining the information of the two different sessions, yielding an
accuracy of 80.9%.
Finally, we assessed different ways of computing the contribu-
tion of each individual classifier to the final decision. Table 6 shows
that results are essentially the same regardless of the function used
for most of experiments. We only found differences in the third and
sixth experiment (69.59% and 80.9%, respectively), where the simplest
estimation of the weight of each classifier led to the largest perfor-
mance. Specifically, weights were computed as the accuracy obtained
by each classifier in the validation set within the inner cross-validation
loop. It is remarkable that the different functions evaluated within
the windowing approach (linear, quadratic and exponential) yielded
poorer or equal performance than using just accuracies as weights.
Section 5 includes a complete interpretation of these results that are
not consistent with previous studies.
5. Discussion
In this study, we proposed a method based on Searchlight to provide
a tool for the early detection of Alzheimer’s disease. We extracted
the accuracy maps derived from this technique and evaluated the
most relevant regions according to an anatomical atlas. Besides, we
compared the performance of this approach with a method based on
PCA, assessing the effect of combining multimodal classifiers (based on
neuroimaging and neuropsychological tests). We used these methods9
six and twelve months before the conversion from MCI to AD, as
well as combining both sessions in ensemble classification. Searchlight
outperformed PCA in all scenarios, especially when the analyses were
focused only on neuroimaging data. Moreover, Searchlight showed a
large stability in the identification of informative regions, resulting the
best option both for classification per se and for identification purposes.
In what follows we discuss the implications for choice of classifica-
tion methods, brain tissues and the influence of different functions
in the combination of individual classifiers associated with ensemble
classification.
5.1. Influence of the classification methods
Our results indicate that the performance provided by PCA is far
from the one obtained by Searchlight. We can separate these ap-
proaches according to the way they deal with the small sample size
problem. Our findings highlight the suitability of Searchlight also for
prediction tasks given its superior performance in all the scenarios
evaluated, not only in terms of accuracy but also in the reduced false
positive rate that it provides. This reveals the suitability of this method
for CAD systems.
The values of the classifier’s accuracy are influenced by the brain
tissues from which features are extracted. Results show a better per-
formance when analyses focused on gray matter both for PCA and
Searchlight. In fact, PCA could hardly obtain above-chance accuracies
when evaluating regions from the white matter. Alzheimer’s disease
is characterized by amyloid plaques accumulating in the gray matter,
leading to neuronal death and cortical thinning (Jang et al., 2017;
Expert Systems With Applications 185 (2021) 115549J.E. Arco et al.Fig. 8. Representation of the brain regions where Searchlight obtained highest accuracies. Regions were extracted from AAL atlas, and only the five with the largest accuracies
are shown. (A) 6 months before conversion. (B) 12 months before conversion.Table 7
Ranking of the most discriminative regions according to their accuracy based on the
AAL atlas. Bold text indicates the regions that were found informative six and twelve
months before the conversion.
6 months before conversion 12 months before conversion
Region Accuracy (%) Region Accuracy (%)
Left Amygdala 64.13 Right Hippocampus 59.18
Left Hippocampus 63.59 Right ParaHippocampal 58.76
Left ParaHippocampal 62.52 Left Hippocampus 58.51
Right ParaHippocampal 60.4 Left Caudate 58.22
Right Hippocampus 59.56 Left Amygdala 58.2
Walsh & Selkoe, 2007). Thus, we could expect that gray matter was the
ideal tissue to be used as input to the classification system. However,
we also obtained a large performance when Searchlight was applied
to white matter. In fact, results were better than the ones obtained by
gray matter twelve months before the conversion session. Many studies
have demonstrated that AD also produces structural changes in white
matter (Barber et al., 1999; Kim et al., 2015), evidencing that white
matter degeneration and demyelination play a crucial role in the risk
and progression of this disease (Ebrahimi Nasrabady et al., 2018). This
strongly indicates that a sensitive technique as Searchlight is able to
detect small differences in white matter between the two groups of
patients.
It is remarkable the large similarity between the most informative
regions identified by Searchlight six and twelve months before the con-
version. Most importantly, these regions have been reported in previous
studies focused on the development of AD. However, we found some
discrepancy between the maximum accuracy obtained by Searchlight
and the average accuracy of the most relevant regions (Tables 3 and
5). This difference must be due to the brain divisions proposed by the
AAL atlas. Some of the regions identified as relevant have a large size
(e.g. left/right parahippocampal), and it is likely that only part of these
regions really contain representative patterns from the two classes to
distinguish. Moreover, slight variations in the spatial organization of
individual brains can reduce the average classification performance of
certain regions.
Another crucial aspect of the results obtained by Searchlight is
related to the spatial information that it provides. It is remarkable that
brain regions with the largest accuracies (amygdala, hippocampus and
parahippocampal gyrus) have been reported by previous research (Eck-
erström et al., 2008; Evans et al., 2018; Lupton et al., 2016; Raunio
et al., 2019), which supports the reliability of the results (see Table 7).
Fig. 8 shows the distribution of these regions. We ran an additional
univariate analysis based on a two-sample t -test to evaluate the dif-
ferences between the two groups in each individual voxel. However,
no statistical tests surpassed the significance threshold (p < 0.05),10remarking that differences between the two groups are not enough to
be identified by univariate methods.
The difficulty of the classification task and the modality of the data
employed for the analysis have a large influence on the performance
of the classifiers. A recent review showed the existence of CAD systems
that obtained accuracies higher than 90% (see Table 2 in Martí-Juan
et al., 2020). The reason for this excellent performance is that those
studies focused on discriminating healthy vs. AD patients. It is impor-
tant to note that this classification is considerably easier than the one
we performed in this work (MCI-C vs. MCI-NC). The levels of brain
atrophy in AD patients are large enough to clearly differentiate from
who do not suffer these dramatic structural changes. However, the
brain atrophy present in some MCI patients produces subtle changes in
the structure of their brain, which sometimes is attributed to age. It is
remarkable that we did not find any significant voxel when applying
a t -test (FWE-corrected for multiple comparisons) between the two
groups, which supports the idea that differences are really subtle. Since
we employed data from previous sessions to the conversion from MCI
to AD, we have provided a classification framework that is able to
distinguish between patients who have been diagnosed with the same
disorder (MCI). Besides, our system also yielded a high performance
(78.26%) twelve months before patients were diagnosed with AD,
which stresses the relevance of our findings. It would be extremely
interesting to evaluate the classification system proposed with data
from sessions more distant to the conversion one. This means that
patients should convert from MCI to AD at the earliest on the fourth
session. However, patients convert on average on the third session,
and only a small percentage of them convert two or three years after
the beginning of the study. This would lead to a reduced dataset,
invalidating the subsequent conclusions derived from the analysis.
Another important aspect is the differential performance of indi-
vidual and ensemble classification. Although the latter provided better
results in all scenarios evaluated, we found large differences when
PCA was used. Specifically, accuracy increased from 63.83% to 73.41%
when applied to gray matter and six months before the conversion
session. However, results showed a slight improvement in the perfor-
mance when Searchlight was applied (from 79.81% to 80.9%). This
is probably due to two main reasons: the modality of the data used
as input to each individual classifier and the way classifiers are fused.
Regarding the second point, we employed a late integration approach,
so that the final output is estimated by combining the outputs of all the
classifiers. Previous research has evidenced that this is the ideal way of
combining multimodal data (Segovia et al., 2016), obtaining a superior
performance than other approaches based on early (combination of the
feature vectors of different modalities before classification) or inter-
mediate integration (multiple kernel learning, Lanckriet et al., 2004).
Thus, the poor boost in performance must be related to the informa-
tion added to neuroimaging, the neuropsychological tests. Our results












evidence that the scores resulting from these tests hardly provides
additional information to the classification framework. Moreover, the
combination of different classifiers could be better when the number of
informative sources increases. According to our results, the maximum
accuracy was obtained when combining images of different sessions
(the two sessions previous to the conversion) and neuropsychological
tests. Future studies should evaluate how results are affected when
different imaging modalities are combined (e.g. PET, SPECT, fMRI,
etc.).
Regarding the windowing technique used to weigh the output of
each individual classifier, results remain stable regardless of the func-
tion used. The weighting function modifies the contribution of each
data modality to the final decision. When images from an only session
are combined with neuropsychological tests, results are exactly the
same for all possible weighting functions. This is not surprising: since
there were only two classifiers, the one that obtained the largest accu-
racy during the inner cross-validation loop was the one with a higher
contribution. When the final decision depends on two classifiers, the
one with largest accuracy decides the final output of the classification
system. This situation changes when more than two classifiers are
combined. Our results show that when images from different sessions
(six and twelve months before the conversion) are combined with
neuropsychological tests (three individual classifiers), the output of the
ensemble classification is affected by how the contribution of each
classifier is computed. Specifically, performance is better when no
specific function is applied, so that the weight of each classifier is given
by the accuracy obtained during the inner cross-validation loop. In
contrast to the current study, Castillo-Barnes et al. (2018) found large
differences in the classification performance depending on the function
associated with the windowing technique. However, they employed a
large number of classifiers from a multiple heterogeneous data sources.
This reinforces the idea that complex relationships between the output
of individual classifiers are appropriate when the number of classifiers
is high. Otherwise, simple relationships can potentially lead to an
optimum performance.
It is worth mentioning an aspect of high relevance that it is not
usually addressed when developing an early-warning classifier for AD.
Most of studies focus on differentiating between MCI-C vs. MCI-NC
ecause it is of core interest to widen our knowledge about the early
tages of AD. MCI-C correspond to patients that have converted to AD
n some session of the longitudinal study. On the other hand, MCI-NC
re diagnosed from MCI at the first session but remain stable until the
nd of the study. This means that when trying to differentiate between
onverters vs. non-converters, the classifier has to distinguish between
atients that are going to convert shortly (6 or 12 months later) and
thers that are all guaranteed not to develop AD for the entire duration
f the study. This difference between the two classes could potentially
ias the results. One possible alternative to alleviate this problem would
onsist on classifying between patients that convert to AD shortly vs.
patients that have been diagnosed as MCI in the first session but do
not convert to AD until many sessions later. We have tried to perform
this comparison with the dataset employed in this work. However,
the number of MCI-C subjects to be divided into the two different
classes (according to their conversion session) is not high enough to
do a rigorous and reliable analysis. It would be highly interesting that
future studies performed by ADNI or other public or private institutions
focus on collecting more data from MCI-C subjects. This would allow
to evaluate in a more realistic context the performance of the CAD
systems.
6. Conclusion
In this study, we provided a classification scheme based on Search-
light to assist in the early diagnosis of AD. We have shown for the first
time that Searchlight provides considerably better results than methods
based on PCA. Although Searchlight has been widely used for the11analysis of the brain function, our results manifest that this approach
can also be employed when maximizing the classification accuracy is
of core interest. Moreover, results are robust for the two sessions of
the longitudinal study evaluated, both in the classification performance
and in the brain regions identified as informative. This is extremely
interesting and supports the idea that the scheme proposed can play a
crucial role in the study of the development of AD. Besides, Searchlight
does not require a previous brain parcellation provided by an atlas
to identify the regions affected by AD, avoiding the potential bias in
the identification when atlases do not match the actual organization
of the brain of all patients. On the other hand, results obtained by
ensemble classification based on PCA show a boost in performance
when combining neuropsychological tests and neuroimaging, but these
differences are considerably lower when the ensemble system relies on
Searchlight. Future studies are needed to evaluate the performance of
these methods when applied to different data modalities such as PET
or SPECT images, which may complement the information provided by
MRI. Besides, the use of longitudinal studies with a longer duration
would allow to assess the ability of the proposed system to detect
the development of AD much earlier than one year before patients
are diagnosed from this disorder. Our results pave the way for using
Searchlight as a tool for computer-aided diagnosis of other neurological
disorders such as Parkinson’s, epilepsy or amyotrophic lateral sclerosis.
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